Viral latency and its regulation: Lessons from the γ-Herpesviruses

Cell Host and Microbe

Volumn 8, Issue 1, 2010, Pages 100-115

  Speck, Samuel H ^a,b   Ganem, Don ^c  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; VIRUS PROTEIN;

B LYMPHOCYTE; EPSTEIN BARR VIRUS; GAMMAHERPESVIRINAE; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 8; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; VIROGENESIS; VIRUS CELL INTERACTION; VIRUS GENOME; VIRUS LATENCY; VIRUS REPLICATION; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY; VIROLOGY;

ANIMALS; GAMMAHERPESVIRINAE; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRIDAE INFECTIONS; HUMANS; VIRAL PROTEINS; VIRUS LATENCY; VIRUS REPLICATION;

EID: 77958183244     PISSN: 19313128     EISSN: 19346069     Source Type: Journal    
DOI: 10.1016/j.chom.2010.06.014     Document Type: Review

References (148)

1. Adler, B., Schaadt, E., Kempkes, B., Zimber-Strobl, U., Baier, B., and Bornkamm, G.W. (2002). Control of Epstein-Barr virus reactivation by activated CD40 and viral latent membrane protein 1. Proc. Natl. Acad. Sci. USA 99, 437-442. (Pubitemid 34060379)
2. Allen, R.D., 3rd, Dickerson, S., and Speck, S.H. (2006). Identification of spliced gammaherpesvirus 68 LANA and v-cyclin transcripts and analysis of their expression in vivo during latent infection. J. Virol. 80, 2055-2062. (Pubitemid 43228746)
3. Ambroziak, J.A., Blackbourn, D.J., Herndier, B.G., Glogau, R.G., Gullett, J.H., McDonald, A.R., Lennette, E.T., and Levy, J.A. (1995). Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients. Science 268, 582-583.
4. Babcock, G.J., Decker, L.L., Volk, M., and Thorley-Lawson, D.A. (1998). EBV persistence in memory B cells in vivo. Immunity 9, 395-404. (Pubitemid 28462760)
5. Ballestas, M.E., and Kaye, K.M. (2001). Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mediates episome persistence through cis-acting terminal repeat (TR) sequence and specifically binds TR DNA. J. Virol. 75, 3250-3258. (Pubitemid 32225888)
6. Ballestas, M.E., Chatis, P.A., and Kaye, K.M. (1999). Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. Science 284, 641-644. (Pubitemid 29289588)
7. Barbera, A.J., Chodaparambil, J.V., Kelley-Clarke, B., Joukov, V., Walter, J.C., Luger, K., and Kaye, K.M. (2006). The nucleosomal surface as a docking station for Kaposi's sarcoma herpesvirus LANA. Science 311, 856-861. (Pubitemid 43228851)
8. Bechtel, J.T., Liang, Y., Hvidding, J., and Ganem, D. (2003). Host range of Kaposi's sarcoma-associated herpesvirus in cultured cells. J. Virol. 77, 6474-6481. (Pubitemid 36588417)
9. Bellare, P., and Ganem, D. (2009). Regulation of KSHV lytic switch protein expression by a virus-encoded microRNA: an evolutionary adaptation that fine-tunes lytic reactivation. Cell Host Microbe 6, 570-575.
10. Bhende, P.M., Seaman, W.T., Delecluse, H.J., and Kenney, S.C. (2004). The EBV lytic switch protein, Z, preferentially binds to and activates the methylated viral genome. Nat. Genet. 36, 1099-1104. (Pubitemid 41184472)
11. Bhende, P.M., Dickerson, S.J., Sun, X., Feng, W.H., and Kenney, S.C. (2007).X-box-binding protein 1 activates lytic Epstein-Barr virus gene expression in combination with protein kinase D. J. Virol. 81, 7363-7370. (Pubitemid 47047825)
12. Blaskovic, D., Stanceková, M., Svobodová, J., and Mistríková, J. (1980). Isolation of five strains of herpesviruses from two species of free living small rodents. Acta Virol. 24, 468.
13. Bornkamm, G.W., and Hammerschmidt, W. (2001). Molecular virology of Epstein-Barr virus. Philos. Trans. R. Soc. Lond. B Biol. Sci. 356, 437-459. (Pubitemid 32442745)
14. Brown, H.J., Song, M.J., Deng, H., Wu, T.T., Cheng, G., and Sun, R. (2003). NF-kappaB inhibits gammaherpesvirus lytic replication. J. Virol. 77, 8532-8540. (Pubitemid 36871481)
15. Bryant, H., and Farrell, P.J. (2002). Signal Transduction and Transcription Factor Modification during Reactivation of Epstein-Barr Virus from Latency. J. Virol. 76, 10290-10298.
16. Cai, X., and Cullen, B.R. (2006). Transcriptional origin of Kaposi's sarcomaassociated herpesvirus microRNAs. J. Virol. 80, 2234-2242. (Pubitemid 43271530)
17. Cai, X., Lu, S., Zhang, Z., Gonzalez, C.M., Damania, B., and Cullen, B.R. (2005). Kaposi's sarcoma-associated herpesvirus expresses an array of viral micro- RNAs in latently infected cells. Proc. Natl. Acad. Sci. USA 102, 5570-5575. (Pubitemid 40530298)
18. Card, G.L., Knowles, P., Laman, H., Jones, N., and McDonald, N.Q. (2000). Crystal structure of a gamma-herpesvirus cyclin-cdk complex. EMBO J. 19, 2877-2888. (Pubitemid 30386760)
19. Cesarman, E., Chang, Y., Moore, P.S., Said, J.W., and Knowles, D.M. (1995). Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDSrelated body-cavity-based lymphomas. N. Engl. J. Med. 332, 1186-1191.
20. Chandriani, S., and Ganem, D. (2010). Array-based transcript profiling and limiting-dilution reverse transcription-PCR analysis identify additional latent genes in Kaposi's sarcoma-associated herpesvirus. J. Virol. 84, 5565-5573.
21. Chang, Y., Moore, P.S., Talbot, S.J., Boshoff, C.H., Zarkowska, T., Godden- Kent, D., Paterson, H., Weiss, R.A., and Mittnacht, S. (1996). Cyclin encoded by KS herpesvirus. Nature 382, 410-411.
22. Chaudhary, P.M., Jasmin, A., Eby, M.T., and Hood, L. (1999). Modulation of the NF-kappa B pathway by virally encoded death effector domains-containing proteins. Oncogene 18, 5738-5746. (Pubitemid 29507427)
23. Chen, J., Ueda, K., Sakakibara, S., Okuno, T., Parravicini, C., Corbellino, M., and Yamanishi, K. (2001). Activation of latent Kaposi's sarcoma-associated herpesvirus by demethylation of the promoter of the lytic transactivator. Proc. Natl. Acad. Sci. USA 98, 4119-4124. (Pubitemid 32249908)
24. Clambey, E.T., Virgin, H.W., 4th, and Speck, S.H. (2000). Disruption of the murine gammaherpesvirus 68 M1 open reading frame leads to enhanced reactivation from latency. J. Virol. 74, 1973-1984. (Pubitemid 30434056)
25. Cohen, A., Wolf, D.G., Guttman-Yassky, E., and Sarid, R. (2005). Kaposi's sarcoma-associated herpesvirus: clinical, diagnostic, and epidemiological aspects. Crit. Rev. Clin. Lab. Sci. 42, 101-153. (Pubitemid 41647726)
26. Cotter, M.A., 2nd, and Robertson, E.S. (1999). The latency-associated nuclear antigen tethers the Kaposi's sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells. Virology 264, 254-264.
27. Deng, H., Liang, Y., and Sun, R. (2007). Regulation of KSHV lytic gene expression. Curr. Top. Microbiol. Immunol. 312, 157-183. (Pubitemid 47400347)
28. Dittmer, D.P. (2003). Transcription profile of Kaposi's sarcoma-associated herpesvirus in primary Kaposi's sarcoma lesions as determined by real-time PCR arrays. Cancer Res. 63, 2010-2015. (Pubitemid 36538598)
29. Dittmer, D., Lagunoff, M., Renne, R., Staskus, K., Haase, A., and Ganem, D. (1998). A cluster of latently expressed genes in Kaposi's sarcoma-associated herpesvirus. J. Virol. 72, 8309-8315. (Pubitemid 28421829)
30. Efklidou, S., Bailey, R., Field, N., Noursadeghi, M., and Collins, M.K. (2008). vFLIP from KSHV inhibits anoikis of primary endothelial cells. J. Cell Sci. 121, 450-457. (Pubitemid 351405053)
31. Evans, A.G., Moser, J.M., Krug, L.T., Pozharskaya, V., Mora, A.L., and Speck, S.H. (2008). A gammaherpesvirus-secreted activator of Vbeta4+ CD8+ T cells regulates chronic infection and immunopathology. J. Exp. Med. 205, 669-684. (Pubitemid 351439312)
32. Feederle, R., Kost, M., Baumann, M., Janz, A., Drouet, E., Hammerschmidt, W., and Delecluse, H.J. (2000). The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators. EMBO J. 19, 3080-3089. (Pubitemid 30386778)
33. Field, N., Low, W., Daniels, M., Howell, S., Daviet, L., Boshoff, C., and Collins, M. (2003). KSHV vFLIP binds to IKK-gamma to activate IKK. J. Cell Sci. 116, 3721-3728. (Pubitemid 37185301)
34. Flaño, E., Husain, S.M., Sample, J.T., Woodland, D.L., and Blackman, M.A. (2000). Latent murine gamma-herpesvirus infection is established in activated B cells, dendritic cells, and macrophages. J. Immunol. 165, 1074-1081. (Pubitemid 30484779)
35. Flaño, E., Kim, I.J., Woodland, D.L., and Blackman, M.A. (2002). Gammaherpesvirus latency is preferentially maintained in splenic germinal center and memory B cells. J. Exp. Med. 196, 1363-1372. (Pubitemid 35375555)
36. Forrest, J.C., and Speck, S.H. (2008). Establishment of B-cell lines latently infected with reactivation-competent murine gammaherpesvirus 68 provides evidence for viral alteration of a DNA damage-signaling cascade. J. Virol. 82, 7688-7699. (Pubitemid 352031234)
37. Forrest, J.C., Paden, C.R., Allen, R.D., 3rd, Collins, J., and Speck, S.H. (2007). ORF73-null murine gammaherpesvirus 68 reveals roles for mLANA and p53 in virus replication. J. Virol. 81, 11957-11971. (Pubitemid 47623827)
38. Fowler, P., Marques, S., Simas, J.P., and Efstathiou, S. (2003). ORF73 of murine herpesvirus-68 is critical for the establishment and maintenance of latency. J. Gen. Virol. 84, 3405-3416. (Pubitemid 37540768)
39. Friborg, J., Jr., Kong, W., Hottiger, M.O., and Nabel, G.J. (1999). p53 inhibition by the LANA protein of KSHV protects against cell death. Nature 402, 889-894.
40. Fujimuro, M., Wu, F.Y., ApRhys, C., Kajumbula, H., Young, D.B., Hayward, G.S., and Hayward, S.D. (2003). A novel viral mechanism for dysregulation of beta-catenin in Kaposi's sarcoma-associated herpesvirus latency. Nat. Med. 9, 300-306. (Pubitemid 36362785)
41. Ganem, D. (2010). KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine. J. Clin. Invest. 120, 939-949.
42. Garber, A.C., Shu, M.A., Hu, J., and Renne, R. (2001). DNA binding and modulation of gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus. J. Virol. 75, 7882-7892. (Pubitemid 32743660)
43. Gottwein, E., and Cullen, B.R. (2010). A human herpesvirus microRNA inhibits p21 expression and attenuates p21-mediated cell cycle arrest. J. Virol. 84, 5229-5237.
44. Gottwein, E., Mukherjee, N., Sachse, C., Frenzel, C., Majoros, W.H., Chi, J.T., Braich, R., Manoharan, M., Soutschek, J., Ohler, U., and Cullen, B.R. (2007). A viral microRNA functions as an orthologue of cellular miR-155. Nature 450, 1096-1099. (Pubitemid 350273603)
45. Grossmann, C., and Ganem, D. (2008). Effects of NFkappaB activation on KSHV latency and lytic reactivation are complex and context-dependent. Virology 375, 94-102.
46. Grundhoff, A., and Ganem, D. (2004). Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis. J. Clin. Invest. 113, 124-136. (Pubitemid 38541639)
47. Guasparri, I., Keller, S.A., and Cesarman, E. (2004). KSHV vFLIP is essential for the survival of infected lymphoma cells. J. Exp. Med. 199, 993-1003. (Pubitemid 38481090)
48. Günther, T., and Grundhoff, A. (2010). The epigenetic landscape of latent Kaposi sarcoma-associated herpesvirus genomes. PLoS Pathog. 6, e1000935.
49. Gutsch, D.E., Holley-Guthrie, E.A., Zhang, Q., Stein, B., Blanar, M.A., Baldwin, A.S., and Kenney, S.C. (1994). The bZIP transactivator of Epstein-Barr virus, BZLF1, functionally and physically interacts with the p65 subunit of NF-kappa B. Mol. Cell. Biol. 14, 1939-1948. (Pubitemid 24074589)
50. Hansen, A., Henderson, S., Lagos, D., Nikitenko, L., Coulter, E., Roberts, S., Gratrix, F., Plaisance, K., Renne, R., Bower, M., et al. (2010). KSHV-encoded miRNAs target MAF to induce endothelial cell reprogramming. Genes Dev. 24, 195-205.
51. Hayward, S.D. (2004). Viral interactions with the Notch pathway. Semin. Cancer Biol. 14, 387-396. (Pubitemid 38993640)
52. Herskowitz, J.H., Siegel, A.M., Jacoby, M.A., and Speck, S.H. (2008). Systematic mutagenesis of the murine gammaherpesvirus 68 M2 protein identifies domains important for chronic infection. J. Virol. 82, 3295-3310. (Pubitemid 351429908)
53. Hoge, A.T., Hendrickson, S.B., and Burns, W.H. (2000). Murine gammaherpesvirus 68 cyclin D homologue is required for efficient reactivation from latency. J. Virol. 74, 7016-7023. (Pubitemid 30470684)
54. Hu, J., Garber, A.C., and Renne, R. (2002). The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus supports latent DNA replication in dividing cells. J. Virol. 76, 11677-11687. (Pubitemid 35231322)
55. Izumi, K.M., and Kieff, E.D. (1997). The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-kappaB. Proc. Natl. Acad. Sci. USA 94, 12592-12597.
56. Izumiya, Y., Izumiya, C., Hsia, D., Ellison, T.J., Luciw, P.A., and Kung, H.J. (2009). NF-kappaB serves as a cellular sensor of Kaposi's sarcoma-associated herpesvirus latency and negatively regulates K-Rta by antagonizing the RBP-Jkappa coactivator. J. Virol. 83, 4435-4446.
57. Johnston, J.B., and McFadden, G. (2003). Poxvirus immunomodulatory strategies: current perspectives. J. Virol. 77, 6093-6100. (Pubitemid 36588380)
58. Jones, C.H., Hayward, S.D., and Rawlins, D.R. (1989). Interaction of the lymphocyte-derived Epstein-Barr virus nuclear antigen EBNA-1 with its DNA-binding sites. J. Virol. 63, 101-110. (Pubitemid 19028087)
59. Kalla, M., Schmeinck, A., Bergbauer, M., Pich, D., and Hammerschmidt, W. (2010). AP-1 homolog BZLF1 of Epstein-Barr virus has two essential functions dependent on the epigenetic state of the viral genome. Proc. Natl. Acad. Sci. USA 107, 850-855.
60. Keller, S.A., Schattner, E.J., and Cesarman, E. (2000). Inhibition of NF-kappaB induces apoptosis of KSHV-infected primary effusion lymphoma cells. Blood 96, 2537-2542.
61. Kim, I.J., Flaño, E., Woodland, D.L., Lund, F.E., Randall, T.D., and Blackman, M.A. (2003). Maintenance of long term gamma-herpesvirus B cell latency is dependent on CD40-mediated development of memory B cells. J. Immunol. 171, 886-892. (Pubitemid 36871401)
62. Kliche, S., Nagel, W., Kremmer, E., Atzler, C., Ege, A., Knorr, T., Koszinowski, U., Kolanus, W., and Haas, J. (2001). Signaling by human herpesvirus 8 kaposin A through direct membrane recruitment of cytohesin-1. Mol. Cell 7, 833-843. (Pubitemid 32436443)
63. Koopal, S., Furuhjelm, J.H., Järviluoma, A., J̈äamaa, S., Pyakurel, P., Pussinen, C., Wirzenius, M., Biberfeld, P., Alitalo, K., Laiho, M., and Ojala, P.M. (2007). Viral oncogene-induced DNA damage response is activated in Kaposi sarcoma tumorigenesis. PLoS Pathog. 3, 1348-1360. (Pubitemid 47510286)
64. Krug, L.T., Moser, J.M., Dickerson, S.M., and Speck, S.H. (2007). Inhibition of NF-kappaB activation in vivo impairs establishment of gammaherpesvirus latency. PLoS Pathog. 3, e11.
65. Krug, L.T., Collins, C.M., Gargano, L.M., and Speck, S.H. (2009). NF-kappaB p50 plays distinct roles in the establishment and control of murine gammaherpesvirus 68 latency. J. Virol. 83, 4732-4748.
66. Lagunoff, M., and Ganem, D. (1997). The structure and coding organization of the genomic termini of Kaposi's sarcoma-associated herpesvirus. Virology 236, 147-154. (Pubitemid 27410362)
67. Laichalk, L.L., and Thorley-Lawson, D.A. (2005). Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo. J. Virol. 79, 1296-1307. (Pubitemid 40053911)
68. Lan, K., Kuppers, D.A., and Robertson, E.S. (2005). Kaposi's sarcoma-associated herpesvirus reactivation is regulated by interaction of latency-associated nuclear antigen with recombination signal sequence-binding protein Jkappa, the major downstream effector of the Notch signaling pathway. J. Virol. 79, 3468-3478. (Pubitemid 40327935)
69. Lee, B.S., Lee, S.H., Feng, P., Chang, H., Cho, N.H., and Jung, J.U. (2005). Characterization of the Kaposi's sarcoma-associated herpesvirus K1 signalosome. J. Virol. 79, 12173-12184. (Pubitemid 41346079)
70. Lei, X., Bai, Z., Ye, F., Xie, J., Kim, C.G., Huang, Y., and Gao, S.J. (2010). Regulation of NF-kappaB inhibitor IkappaBalpha and viral replication by a KSHV microRNA. Nat. Cell Biol. 12, 193-199.
71. Leight, E.R., and Sugden, B. (2001). Establishment of an oriP replicon is dependent upon an infrequent, epigenetic event. Mol. Cell. Biol. 21, 4149-4161. (Pubitemid 32565297)
72. Li, H., Komatsu, T., Dezube, B.J., and Kaye, K.M. (2002). The Kaposi's sarcoma-associated herpesvirus K12 transcript from a primary effusion lymphoma contains complex repeat elements, is spliced, and initiates from a novel promoter. J. Virol. 76, 11880-11888. (Pubitemid 35304288)
73. Li, Q., Zhou, F., Ye, F., and Gao, S.J. (2008). Genetic disruption of KSHV major latent nuclear antigen LANA enhances viral lytic transcriptional program. Virology 379, 234-244.
74. Liang, Y., and Ganem, D. (2003). Lytic but not latent infection by Kaposi's sarcoma-associated herpesvirus requires host CSL protein, the mediator of Notch signaling. Proc. Natl. Acad. Sci. USA 100, 8490-8495. (Pubitemid 36842572)
75. Liang, Y., Chang, J., Lynch, S.J., Lukac, D.M., and Ganem, D. (2002). The lytic switch protein of KSHV activates gene expression via functional interaction with RBP-Jkappa (CSL), the target of the Notch signaling pathway. Genes Dev. 16, 1977-1989. (Pubitemid 34832925)
76. Liang, X., Pickering, M.T., Cho, N.H., Chang, H., Volkert, M.R., Kowalik, T.F., and Jung, J.U. (2006). Deregulation of DNA damage signal transduction by herpesvirus latency-associated M2. J. Virol. 80, 5862-5874. (Pubitemid 43849164)
77. Liang, X., Collins, C.M., Mendel, J.B., Iwakoshi, N.N., and Speck, S.H. (2009). Gammaherpesvirus-driven plasma cell differentiation regulates virus reactivation from latently infected B lymphocytes. PLoS Pathog. 5, e1000677.
78. Lin, C.W., Tu, P.F., Hsiao, N.W., Chang, C.Y., Wan, L., Lin, Y.T., and Chang, H.W. (2007). Identification of a novel septin 4 protein binding to human herpesvirus 8 kaposin A protein using a phage display cDNA library. J. Virol. Methods 143, 65-72. (Pubitemid 46802826)
79. Liu, L., Eby, M.T., Rathore, N., Sinha, S.K., Kumar, A., and Chaudhary, P.M. (2002). The human herpes virus 8-encoded viral FLICE inhibitory protein physically associates with and persistently activates the Ikappa B kinase complex. J. Biol. Chem. 277, 13745-13751. (Pubitemid 34967977)
80. Lukac, D.M., Renne, R., Kirshner, J.R., and Ganem, D. (1998). Reactivation of Kaposi's sarcoma-associated herpesvirus infection from latency by expression of the ORF 50 transactivator, a homolog of the EBV R protein. Virology 252, 304-312. (Pubitemid 29013411)
81. Lukac, D.M., Kirshner, J.R., and Ganem, D. (1999). Transcriptional activation by the product of open reading frame 50 of Kaposi's sarcoma-associated herpesvirus is required for lytic viral reactivation in B cells. J. Virol. 73, 9348-9361. (Pubitemid 29487090)
82. Mannick, J.B., Cohen, J.I., Birkenbach, M., Marchini, A., and Kieff, E. (1991). The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation. J. Virol. 65, 6826-6837.
83. Marshall, V., Parks, T., Bagni, R., Wang, C.D., Samols, M.A., Hu, J., Wyvil, K.M., Aleman, K., Little, R.F., Yarchoan, R., et al. (2007). Conservation of virally encoded microRNAs in Kaposi sarcoma-associated herpesvirus in primary effusion lymphoma cell lines and in patients with Kaposi sarcoma or multicentric Castleman disease. J. Infect. Dis. 195, 645-659.
84. McCormick, C., and Ganem, D. (2005). The kaposin B protein of KSHV activates the p38/MK2 pathway and stabilizes cytokine mRNAs. Science 307, 739-741. (Pubitemid 40194646)
85. McGeoch, D.J., Gatherer, D., and Dolan, A. (2005). On phylogenetic relationships among major lineages of the Gammaherpesvirinae. J. Gen. Virol. 86, 307-316. (Pubitemid 40227941)
86. Moorman, N.J., Willer, D.O., and Speck, S.H. (2003b). The gammaherpesvirus 68 latency-associated nuclear antigen homolog is critical for the establishment of splenic latency. J. Virol. 77, 10295-10303. (Pubitemid 37129673)
87. Moorman, N.J., Lin, C.Y., and Speck, S.H. (2004). Identification of candidate gammaherpesvirus 68 genes required for virus replication by signature-tagged transposon mutagenesis. J. Virol. 78, 10282-10290. (Pubitemid 39258353)
88. Muralidhar, S., Pumfery, A.M., Hassani, M., Sadaie, M.R., Kishishita, M., Brady, J.N., Doniger, J., Medveczky, P., Rosenthal, L.J., and Rosenthal, L.J. (1998). Identification of kaposin (open reading frame K12) as a human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) transforming gene. J. Virol. 72, 4980-4988. (Pubitemid 28215678)
89. Paden, C.R., Forrest, J.C., Moorman, N.J., and Speck, S.H. (2010). Murine gammaherpesvirus 68 LANA is essential for virus reactivation from splenocytes but not long-term carriage of viral genome. J. Virol. 84, 7214-7224.
90. Paulson, E.J., and Speck, S.H. (1999). Differential methylation of Epstein-Barr virus latency promoters facilitates viral persistence in healthy seropositive individuals. J. Virol. 73, 9959-9968.
91. Pearce, M., Matsumura, S., and Wilson, A.C. (2005). Transcripts encoding K12, v-FLIP, v-cyclin, and the microRNA cluster of Kaposi's sarcoma-associated herpesvirus originate from a common promoter. J. Virol. 79, 14457-14464. (Pubitemid 41552745)
92. Pfeffer, S., Sewer, A., Lagos-Quintana, M., Sheridan, R., Sander, C., Grässer, F.A., van Dyk, L.F., Ho, C.K., Shuman, S., Chien, M., et al. (2005). Identification of microRNAs of the herpesvirus family. Nat. Methods 2, 269-276. (Pubitemid 41131008)
93. Piolot, T., Tramier, M., Coppey, M., Nicolas, J.C., and Marechal, V. (2001). Close but distinct regions of human herpesvirus 8 latency-associated nuclear antigen 1 are responsible for nuclear targeting and binding to human mitotic chromosomes. J. Virol. 75, 3948-3959. (Pubitemid 32246403)
94. Pires de Miranda, M., Alenquer, M., Marques, S., Rodrigues, L., Lopes, F., Bustelo, X.R., and Simas, J.P. (2008). The Gammaherpesvirus m2 protein manipulates the Fyn/Vav pathway through a multidocking mechanism of assembly. PLoS ONE 3, e1654.
95. Radkov, S.A., Kellam, P., and Boshoff, C. (2000). The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells. Nat. Med. 6, 1121-1127.
96. Ragoczy, T., Heston, L., and Miller, G. (1998). The Epstein-Barr virus Rta protein activates lytic cycle genes and can disrupt latency in B lymphocytes. J. Virol. 72, 7978-7984. (Pubitemid 28421790)
97. Rappocciolo, G., Hensler, H.R., Jais, M., Reinhart, T.A., Pegu, A., Jenkins, F.J., and Rinaldo, C.R. (2008). Human herpesvirus 8 infects and replicates in primary cultures of activated B lymphocytes through DC-SIGN. J. Virol. 82, 4793-4806. (Pubitemid 351657041)
98. Reisman, D., Yates, J., and Sugden, B. (1985). A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis-acting components. Mol. Cell. Biol. 5, 1822-1832. (Pubitemid 15049139)
99. Renne, R., Lagunoff, M., Zhong, W., and Ganem, D. (1996a). The size and conformation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in infected cells and virions. J. Virol. 70, 8151-8154. (Pubitemid 26339129)
100. Rickabaugh, T.M., Brown, H.J., Martinez-Guzman, D., Wu, T.T., Tong, L., Yu, F., Cole, S., and Sun, R. (2004). Generation of a latency-deficient gammaherpesvirus that is protective against secondary infection. J. Virol. 78, 9215-9223. (Pubitemid 39096531)
101. Rickinson, A., and Kieff, E. (1996). Epstein-Barr virus. In Fields' Virology, Third Edition, B.N. Fields, D.M. Knipe, P.M. Howley, R.M. Chanock, L.L. Melnick, T.P. Monath, B. Roizmann, and S.E. Strauss, eds. (Philadephia, PA: Lippincott- Raven), pp. 2397-2446.
102. Rivas, C., Thlick, A.E., Parravicini, C., Moore, P.S., and Chang, Y. (2001). Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53. J. Virol. 75, 429-438.
103. Rodrigues, L., Filipe, J., Seldon, M.P., Fonseca, L., Anrather, J., Soares, M.P., and Simas, J.P. (2009). Termination of NF-kappaB activity through a gammaherpesvirus protein that assembles an EC5S ubiquitin-ligase. EMBO J. 28, 1283-1295.
104. Sadler, R., Wu, L., Forghani, B., Renne, R., Zhong, W., Herndier, B., and Ganem, D. (1999). A complex translational program generates multiple novel proteins from the latently expressed kaposin (K12) locus of Kaposi's sarcoma-associated herpesvirus. J. Virol. 73, 5722-5730. (Pubitemid 29274858)
105. Sakakibara, S., Pise-Masison, C.A., Brady, J.N., and Tosato, G. (2009). Gene regulation and functional alterations induced by Kaposi's sarcoma-associated herpesvirus-encoded ORFK13/vFLIP in endothelial cells. J. Virol. 83, 2140-2153.
106. Samols, M.A., Hu, J., Skalsky, R.L., and Renne, R. (2005). Cloning and identification of a microRNA cluster within the latency-associated region of Kaposi's sarcoma-associated herpesvirus. J. Virol. 79, 9301-9305. (Pubitemid 40934841)
107. Samols, M.A., Skalsky, R.L., Maldonado, A.M., Riva, A., Lopez, M.C., Baker, H.V., and Renne, R. (2007). Identification of cellular genes targeted by KSHV-encoded microRNAs. PLoS Pathog. 3, e65.
108. Sample, J., Henson, E.B., and Sample, C. (1992). The Epstein-Barr virus nuclear protein 1 promoter active in type I latency is autoregulated. J. Virol. 66, 4654-4661.
109. Schaefer, B.C., Strominger, J.L., and Speck, S.H. (1995). Redefining the Epstein- Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell lines. Proc. Natl. Acad. Sci. USA 92, 10565-10569.
110. Schaefer, B.C., Paulson, E., Strominger, J.L., and Speck, S.H. (1997). Constitutive activation of Epstein-Barr virus (EBV) nuclear antigen 1 gene transcription by IRF1 and IRF2 during restricted EBV latency. Mol. Cell. Biol. 17, 873-886. (Pubitemid 27044387)
111. Schäfer, A., Cai, X., Bilello, J.P., Desrosiers, R.C., and Cullen, B.R. (2007). Cloning and analysis of microRNAs encoded by the primate gamma-herpesvirus rhesus monkey rhadinovirus. Virology 364, 21-27. (Pubitemid 46829292)
112. Schwam, D.R., Luciano, R.L., Mahajan, S.S., Wong, L., and Wilson, A.C. (2000). Carboxy terminus of human herpesvirus 8 latency-associated nuclear antigen mediates dimerization, transcriptional repression, and targeting to nuclear bodies. J. Virol. 74, 8532-8540. (Pubitemid 30666704)
113. Sears, J., Ujihara, M., Wong, S., Ott, C., Middeldorp, J., and Aiyar, A. (2004). The amino terminus of Epstein-Barr Virus (EBV) nuclear antigen 1 contains AT hooks that facilitate the replication and partitioning of latent EBV genomes by tethering them to cellular chromosomes. J. Virol. 78, 11487-11505. (Pubitemid 39390736)
114. Skalsky, R.L., Hu, J., and Renne, R. (2007a). Analysis of viral cis elements conferring Kaposi's sarcoma-associated herpesvirus episome partitioning and maintenance. J. Virol. 81, 9825-9837. (Pubitemid 350067686)
115. Skalsky, R.L., Samols, M.A., Plaisance, K.B., Boss, I.W., Riva, A., Lopez, M.C., Baker, H.V., and Renne, R. (2007b). Kaposi's sarcoma-associated herpesvirus encodes an ortholog of miR-155. J. Virol. 81, 12836-12845. (Pubitemid 350156921)
116. Song, M.J., Deng, H., and Sun, R. (2003). Comparative study of regulation of RTA-responsive genes in Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8. J. Virol. 77, 9451-9462. (Pubitemid 37011041)
117. Song, M.J., Hwang, S., Wong, W.H., Wu, T.T., Lee, S., Liao, H.I., and Sun, R. (2005). Identification of viral genes essential for replication of murine gammaherpesvirus 68 using signature-tagged mutagenesis. Proc. Natl. Acad. Sci. USA 102, 3805-3810. (Pubitemid 40354693)
118. Soulier, J., Grollet, L., Oksenhendler, E., Cacoub, P., Cazals-Hatem, D., Babinet, P., d'Agay, M.F., Clauvel, J.P., Raphael, M., Degos, L., et al. (1995). Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 86, 1276-1280.
119. Speck, S.H. (2005). Regulation of EBV latency-associated gene expression. In Epstein-Barr Virus, E.S. Robertson, ed. (Norfolk, England: Caister Academic Press), pp. 403-428.
120. Speck, S.H., Chatila, T., and Flemington, E. (1997). Reactivation of Epstein- Barr virus: regulation and function of the BZLF1 gene. Trends Microbiol. 5, 399-405. (Pubitemid 27417826)
121. Steed, A., Buch, T., Waisman, A., and Virgin, H.W., 4th. (2007). Gamma interferon blocks gammaherpesvirus reactivation from latency in a cell typespecific manner. J. Virol. 81, 6134-6140. (Pubitemid 46847051)
122. Sun, C.C., and Thorley-Lawson, D.A. (2007). Plasma cell-specific transcription factor XBP-1s binds to and transactivates the Epstein-Barr virus BZLF1 promoter. J. Virol. 81, 13566-13577. (Pubitemid 350247850)
123. Sun, R., Lin, S.F., Gradoville, L., Yuan, Y., Zhu, F., and Miller, G. (1998). A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus. Proc. Natl. Acad. Sci. USA 95, 10866-10871.
124. Sunil-Chandra, N.P., Efstathiou, S., and Nash, A.A. (1992). Murine gammaherpesvirus 68 establishes a latent infection in mouse B lymphocytes in vivo. J. Gen. Virol. 73, 3275-3279. (Pubitemid 23014183)
125. Swanton, C., Card, G.L., Mann, D., McDonald, N., and Jones, N. (1999). Overcoming inhibitions: subversion of CKI function by viral cyclins. Trends Biochem. Sci. 24, 116-120. (Pubitemid 29225246)
126. Tao, Q., and Robertson, K.D. (2003). Stealth technology: how Epstein-Barr virus utilizes DNA methylation to cloak itself from immune detection. Clin. Immunol. 109, 53-63. (Pubitemid 37324742)
127. Tempera, I., and Lieberman, P.M. (2010). Chromatin organization of gammaherpesvirus latent genomes. Biochim. Biophys. Acta 1799, 236-245.
128. Thorley-Lawson, D.A. (2001). Epstein-Barr virus: exploiting the immune system. Nat. Rev. Immunol. 1, 75-82. (Pubitemid 33741978)
129. Thorley-Lawson, D.A., Duca, K.A., and Shapiro, M. (2008). Epstein-Barr virus: a paradigmfor persistent infection - for real and in virtual reality. Trends Immunol. 29, 195-201.
130. Thurau, M., Marquardt, G., Gonin-Laurent, N., Weinländer, K., Naschberger, E., Jochmann, R., Alkharsah, K.R., Schulz, T.F., Thome, M., Neipel, F., and Stürzl, M. (2009). Viral inhibitor of apoptosis vFLIP/K13 protects endothelial cells against superoxide-induced cell death. J. Virol. 83, 598-611.
131. Umbach, J.L., and Cullen, B.R. (2010). In-depth analysis of Kaposi's sarcomaassociated herpesvirus microRNA expression provides insights into the mammalian microRNA-processing machinery. J. Virol. 84, 695-703.
132. Upton, J.W., and Speck, S.H. (2006). Evidence for CDK-dependent and CDKindependent functions of the murine gammaherpesvirus 68 v-cyclin. J. Virol. 80, 11946-11959. (Pubitemid 44904344)
133. van Dyk, L.F., Virgin, H.W., 4th, and Speck, S.H. (2000). The murine gammaherpesvirus 68 v-cyclin is a critical regulator of reactivation from latency. J. Virol. 74, 7451-7461. (Pubitemid 30613090)
134. Virgin, H.W., 4th, Latreille, P., Wamsley, P., Hallsworth, K., Weck, K.E., Dal Canto, A.J., and Speck, S.H. (1997). Complete sequence and genomic analysis of murine gammaherpesvirus 68. J. Virol. 71, 5894-5904. (Pubitemid 27304926)
135. Weck, K.E., Kim, S.S., Virgin HW, I.V., and Speck, S.H. (1999a). B cells regulate murine gammaherpesvirus 68 latency. J. Virol. 73, 4651-4661. (Pubitemid 29246723)
136. Weck, K.E., Kim, S.S., Virgin HW, I.V., and Speck, S.H. (1999b). Macrophages are the major reservoir of latent murine gammaherpesvirus 68 in peritoneal cells. J. Virol. 73, 3273-3283. (Pubitemid 29135720)
137. Willer, D.O., and Speck, S.H. (2003). Long-term latent murine Gammaherpesvirus 68 infection is preferentially found within the surface immunoglobulin D-negative subset of splenic B cells in vivo. J. Virol. 77, 8310-8321. (Pubitemid 36871459)
138. Willer, D.O., and Speck, S.H. (2005). Establishment and maintenance of longterm murine gammaherpesvirus 68 latency in B cells in the absence of CD40. J. Virol. 79, 2891-2899. (Pubitemid 40270567)
139. Wilson, S.J., Tsao, E.H., Webb, B.L., Ye, H., Dalton-Griffin, L., Tsantoulas, C., Gale, C.V., Du, M.Q., Whitehouse, A., and Kellam, P. (2007). X box binding protein XBP-1s transactivates the Kaposi's sarcoma-associated herpesvirus (KSHV) ORF50 promoter, linking plasma cell differentiation to KSHV reactivation from latency. J. Virol. 81, 13578-13586. (Pubitemid 350247851)
140. Xu, Y., and Ganem, D. (2007). Induction of chemokine production by latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells. J. Gen. Virol. 88, 46-50. (Pubitemid 46085113)
141. Xu, Y., AuCoin, D.P., Huete, A.R., Cei, S.A., Hanson, L.J., and Pari, G.S. (2005). A Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 ORF50 deletion mutant is defective for reactivation of latent virus and DNA replication. J. Virol. 79, 3479-3487. (Pubitemid 40327936)
142. Yates, J.L., Warren, N., and Sugden, B. (1985). Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature 313, 812-815. (Pubitemid 15130835)
143. Ye, F.C., Zhou, F.C., Xie, J.P., Kang, T., Greene, W., Kuhne, K., Lei, X.F., Li, Q.H., and Gao, S.J. (2008). Kaposi's sarcoma-associated herpesvirus latent gene vFLIP inhibits viral lytic replication through NF-kappaB-mediated
144. Yu, F., Harada, J.N., Brown, H.J., Deng, H., Song, M.J., Wu, T.T., Kato-Stankiewicz, J., Nelson, C.G., Vieira, J., Tamanoi, F., et al. (2007a). Systematic identification of cellular signals reactivating Kaposi sarcoma-associated herpesvirus. PLoS Pathog. 3, e44.
145. Yu, F., Feng, J., Harada, J.N., Chanda, S.K., Kenney, S.C., and Sun, R. (2007b). B cell terminal differentiation factor XBP-1 induces reactivation of Kaposi's sarcoma-associated herpesvirus. FEBS Lett. 581, 3485-3488. (Pubitemid 47048199)
146. Zalani, S., Holley-Guthrie, E., and Kenney, S. (1996). Epstein-Barr viral latency is disrupted by the immediate-early BRLF1 protein through a cell-specific mechanism. Proc. Natl. Acad. Sci. USA 93, 9194-9199. (Pubitemid 26282040)
147. Zhao, J., Punj, V., Matta, H., Mazzacurati, L., Schamus, S., Yang, Y., Yang, T., Hong, Y., and Chaudhary, P.M. (2007). K13 blocks KSHV lytic replication and deregulates vIL6 and hIL6 expression: a model of lytic replication induced clonal selection in viral oncogenesis. PLoS ONE 2, e1067.
148. Ziegelbauer, J.M., Sullivan, C.S., and Ganem, D. (2009). Tandem array-based expression screens identify host mRNA targets of virus-encoded microRNAs. Nat. Genet. 41, 130-134.